Global Information
회사소개 | 문의 | 비교리스트

세계의 DNA 시퀀싱 시장

DNA Sequencing

리서치사 Global Industry Analysts, Inc.
발행일 2022년 01월 상품 코드 913112
페이지 정보 영문 274 Pages
가격
US $ 4,950 ₩ 5,962,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 17,886,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 DNA 시퀀싱 시장 DNA Sequencing
발행일 : 2022년 01월 페이지 정보 : 영문 274 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 DNA 시퀀싱(DNA Sequencing) 시장을 조사했으며, 시장의 개요, 용도(진단, Drug Discovery, 바이오마커 개발, 맞춤형 의료, 농업·동물 연구, 기타), 최종사용자(연구 센터·학술기관·정부계 기관, 바이오테크놀러지 기업, 제약기업, 병원·진료소, 기타), 지역별 시장 점유율, 수요 동향, 매출액의 추이와 예측, 시장 성장요인, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

  • 시장 개요
    • 경쟁사의 시장 점유율
    • 경쟁사의 시장 점유율 : 시나리오
  • 주목 기업
  • 시장 동향과 성장요인
  • 세계 시장 전망

제3장 시장 분석

  • 지역 시장 분석
  • 미국
    • 시장 개요
    • 시장 점유율 : 기업별
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽 국가
  • 아시아태평양
  • 기타 지역

제4장 경쟁 구도

  • F. HOFFMANN-LA ROCHE AG
  • ILLUMINA
  • PACIFIC BIOSCIENCES OF CALIFORNIA
  • THERMO FISHER SCIENTIFIC

제5장 조사 자료

KSA 19.12.18

Abstract:

Global DNA Sequencing Market to Reach US$10.1 Billion by the Year 2026

Deoxyribonucleic acid (DNA) sequencing involves process of determining sequence of four nucleotides bases namely, adenine, cytosine, guanine, and thymine present in DNA. The advanced technology assists healthcare professionals in easily comparing mutated and healthy DNA. This allows them to easily diagnose and provide effective treatment for various life threatening ailments such as cancer. Growth in the global market is set to be driven by promising opportunities in the fields of biomarkers, cancer, diagnostics, personalized medicine, forensics and reproductive health among others. The increase in genome mapping programs worldwide, rise in partnerships and collaborations, and growing technological developments in DNA sequencing are the other factors promoting growth in the market. Evolving technology, growing incidence of cancer, the emergence of new market players, increasing requirements of breeders for the reproduction of plants and animals, increase in programs for genome mapping, increased conferences and seminars on DNA sequencing market, development in applications for liquid biopsy, the continued drop in costs of sequencing, and growing personalized therapies are also expected to fuel growth. Driven by promising outlook, DNA sequencing is widely being used for conducting biological research, medical diagnosis, as well as performing biotechnology experiments.

Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$10.1 Billion by 2026, growing at a CAGR of 11.8% over the analysis period. Consumables, one of the segments analyzed in the report, is projected to grow at a 11.4% CAGR to reach US$4.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.6% CAGR for the next 7-year period. This segment currently accounts for a 28.9% share of the global DNA Sequencing market. Consumables such as kits and reagents and tools simplify and streamline the workflows. Due to their sheer use and requirement during the library building, sample preparation, and pre-requisite steps for DNA sequencing, the consumables product segment holds dominant position in the market.

The U.S. Market is Estimated at $2.4 Billion in 2021, While China is Forecast to Reach $1.3 Billion by 2026

The DNA Sequencing market in the U.S. is estimated at US$2.4 Billion in the year 2021. The country currently accounts for a 41.4% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.3 Billion in the year 2026 trailing a CAGR of 17.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR while Rest of European market (as defined in the study) will reach US$1.5 Billion by the end of the analysis period. North America region leads the market due to technological advances and the growing prevalence of genetic diseases among patients. Increased funding by government organizations in DNA sequencing research and development is also fueling the growth of the market in the region. The Asia Pacific region has emerged as a nascent DNA sequencing market, leading with massive contributions from some countries in Asia including India, China, South Korea, and Japan. The increasing geriatric population and rising incidences of tumors in this region have had a positive effect on the growth of the market for DNA sequencing in this region.

Services Segment to Reach $3.1 Billion by 2026

The factors driving demand for the market of DNA sequencing services are increased funding for life science research and public grants, technological developments in the diagnosis and treatment method of infectious diseases, innovation in molecular techniques, and customized product offerings. In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$140.8 Million by the year 2026.

Select Competitors (Total 76 Featured) -

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Macrogen, Inc.
  • Perkin Elmer, Inc.
  • Pacific Biosciences of California, Inc.
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics
  • PierianDx
  • Intrexon Bioinformatics Germany GmbH
  • Eurofins Scientific

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • An Introduction
    • A Brief History on Evolution of DNA Sequencing Technology
    • Different Types of Sequencing Approaches
    • Shotgun Sequencing
    • High-Throughput Approach
    • Long-Read Sequencing Approaches
    • Single Molecule Real Time (SMRT) Sequencing
    • Nanopore DNA Sequencing
    • Short-Read Sequencing Approaches
    • Massively Parallel Signature Sequencing (MPSS)
    • Polony Sequencing
    • 454 Pyrosequencing
    • Illumina (Solexa) Sequencing
    • Combinatorial Probe Anchor Synthesis (cPAS)
    • SOLiD sequencing
    • Ion Torrent Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Heliscope Single Molecule Sequencing
    • Microfluidic Systems
    • A Prelude to DNA Sequencing
    • Major Applications
    • DNA Sequencing Application
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Impact of COVID-19 on DNA Sequencing Market
    • Global Market Prospects and Outlook
    • DNA Sequencing Market Set for a Rapid Growth
    • Regional Market Perspective
    • North America Leads the Global Market
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Next Generation Sequencing Drives the Market Growth
    • Increasing R&D Activities in NGS
    • Illumina, the Dominant Force in the Global NGS Market
    • The Market for DNA Sequencing in Europe amid the Pandemic
    • Growing Adoption of Sequencing Services in Clinical Workflows Propels Market Growth
    • Increasing Use in Drug Discovery Drives Market Growth
    • Increasing Emphasis on Personalized Medicine Drives Market Growth
    • EXHIBIT 2: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rising Incidence of Cancer to Drive Market Growth
    • EXHIBIT 3: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 4: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • EXHIBIT 5: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • DNA Sequencing and Cancer Care
    • Technological Advancements in NGFS Aids Market Expansion
    • The First Mobile Genome Sequence Analyzer in the World
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Clinical Investigation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Clinical Investigation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Forensics & Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Forensics & Agrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for HLA Typing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for HLA Typing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 28: World Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 31: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 34: World Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 37: World Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 38: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: World 15-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 40: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 43: World Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 44: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
    • TABLE 46: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 47: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 49: USA Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: USA 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 52: USA Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: USA Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: USA 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 55: USA Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: USA Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: USA 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 58: Canada Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Canada 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 61: Canada Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Canada Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Canada 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 64: Canada Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Canada Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Canada 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 67: Japan Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Japan Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Japan 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 70: Japan Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Japan Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Japan 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 73: Japan Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Japan Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Japan 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 76: China Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: China Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: China 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 79: China Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: China Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: China 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 82: China Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: China Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: China 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 85: Europe Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 86: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Europe 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 88: Europe Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Europe 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 91: Europe Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 94: Europe Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 97: France Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: France Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: France 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 100: France Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: France Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: France 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 103: France Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: France Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: France 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 106: Germany Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Germany Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Germany 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 109: Germany Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Germany Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Germany 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 112: Germany Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Germany Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Germany 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 115: Italy Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Italy Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Italy 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 118: Italy Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Italy Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Italy 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 121: Italy Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Italy Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Italy 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 124: UK Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: UK Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: UK 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 127: UK Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: UK Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: UK 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 130: UK Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: UK Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: UK 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 133: Rest of Europe Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 142: Asia-Pacific Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF WORLD
    • TABLE 151: Rest of World Current & Future Analysis for DNA Sequencing by Product - Consumables, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Rest of World Historic Review for DNA Sequencing by Product - Consumables, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Rest of World 15-Year Perspective for DNA Sequencing by Product - Percentage Breakdown of Value Revenues for Consumables, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 154: Rest of World Current & Future Analysis for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Rest of World Historic Review for DNA Sequencing by Application - Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Rest of World 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Revenues for Oncology, Reproductive Health, Clinical Investigation, Forensics & Agrigenomics, HLA Typing, Consumer Genomics and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 157: Rest of World Current & Future Analysis for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of World Historic Review for DNA Sequencing by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Rest of World 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Revenues for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 76
Back to Top
전화 문의
F A Q